Vandria Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series B
  • (Cancelled)

  • Investors
  • 6

Vandria General Information

Description

Developer of mitophagy inducers designed to rejuvenate cells to treat age-related and chronic diseases. The company's inducers are a key pathway by which portions of damaged mitochondria are eliminated and recycled using the autophagy machinery and are required to maintain proper mitochondrial function, enabling patients to avoid diseases due to old age.

Contact Information

Website
www.vandria.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Route de la Corniche 8
  • Epalinges
  • 1066 Lausanne
  • Switzerland
Primary Industry
Biotechnology
Vertical(s)
LOHAS & Wellness, Life Sciences
Corporate Office
  • Route de la Corniche 8
  • Epalinges
  • 1066 Lausanne
  • Switzerland

Vandria Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vandria Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC (Series B) 02-Dec-2025 Cancelled Clinical Trials - Phase 1
5. Early Stage VC (Series A) 21-Aug-2024 Completed Pre-Clinical Trials
4. Accelerator/Incubator Completed Pre-Clinical Trials
3. Grant 08-Feb-2024 Completed Pre-Clinical Trials
2. Early Stage VC (Series A) 14-Dec-2023 $20.5M $20.5M Completed Pre-Clinical Trials
1. Early Stage VC 01-Jan-2022 Completed Startup
To view Vandria’s complete valuation and funding history, request access »

Vandria Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary Shares
To view Vandria’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Vandria Patents

  • 33

    Total Documents Applications and Grants

  • Total Patents Families

  • 8

    Granted

  • 17

    Pending

  • Expiring in next 12 mo

Vandria Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024271312-A1 Use of urolithin derivatives in the treatment of amyotrophic lateral sclerosis Pending 18-May-2023
EP-4712958-A2 Use of urolithin derivatives in the treatment of amyotrophic lateral sclerosis Pending 18-May-2023
US-20240424006-A1 Use of urolithin derivatives in the treatment of amyotrophic lateral sclerosis Pending 18-May-2023
WO-2024236367-A2 Use of urolithin derivatives in the treatment of amyotrophic lateral sclerosis Inactive 18-May-2023
WO-2024236367-A3 Use of urolithin derivatives in the treatment of amyotrophic lateral sclerosis Inactive 18-May-2023 A61K31/343
To view Vandria’s complete patent history, request access »

Vandria Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vandria Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Dolby Family Ventures Venture Capital Minority
Hevolution Foundation Corporation Minority
Eurostars Other Minority
Innosuisse Government
ND Capital Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Vandria FAQs

  • When was Vandria founded?

    Vandria was founded in 2021.

  • Where is Vandria headquartered?

    Vandria is headquartered in Lausanne, Switzerland.

  • What is the size of Vandria?

    Vandria has 10 total employees.

  • What industry is Vandria in?

    Vandria’s primary industry is Biotechnology.

  • Is Vandria a private or public company?

    Vandria is a Private company.

  • What is Vandria’s current revenue?

    The current revenue for Vandria is .

  • How much funding has Vandria raised over time?

    Vandria has raised $32.3M.

  • Who are Vandria’s investors?

    Dolby Family Ventures, Hevolution Foundation, Eurostars, Innosuisse, and ND Capital are 5 of 6 investors who have invested in Vandria.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process